Ovarian endometriosis

Summary

Ovarian endometriosis (MONDO:0006337) is a disease and 2 clinical trials. A subtype of endometriosis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 2

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	ovarian endometriosis
Mondo ID	MONDO:0006337
EFO	EFO:1000418
DOID	DOID:11432
ICD-10-CM	N80.1
NCIT	C27628
SNOMED CT	266589005
UMLS	C0156344
MedGen	102350
Anatomy (UBERON)	UBERON:0000992
Is cancer (heuristic)	no

Also known as: endometriosis (disease) of ovary · endometriosis of ovary · ovarian endometriosis · ovary endometriosis (disease)

Disease family

This is a subtype of endometriosis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › reproductive system disorder › female reproductive system disorder › uterine disorder › endometrial disorder › endometriosis › ovarian endometriosis

Related subtypes (6): fallopian tube endometriosis, endometriosis of intestine, endometriosis of pelvic peritoneum, endometriosis in cutaneous scar, endometriosis of rectovaginal septum and vagina, cervix endometriosis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 2.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	2

Top trials by phase / activity

NCT	Phase	Status	Title
NCT05357924	Not specified	UNKNOWN	Evaluating Ovarian Reserve After Conventional Laparoscopy Versus Robotic Surgery for Bilateral Endometrioma
NCT06219044	Not specified	COMPLETED	Evaluation of Ovarian Reserve and Recurrence Rate After DWLS Diode Laser OMA Vaporization